Romosozumab antibody | AbD60146
Human anti Romosozumab:HRP
- Product Type
- Monoclonal Antibody
- Clone
- AbD60146
- Isotype
- Fab antibody
- Specificity
- Romosozumab
Filter by Application:
E Reset| Human Anti-Romosozumab Antibody, clone AbD60146 is a paratope specific, inhibitory, anti-idiotypic antibody (Type 1) that specifically recognizes the free human monoclonal antibody drug romosozumab, and its biosimilar products. It does not recognize the drug target, sclerostin, nor romosozumab in complex with sclerostin. This antibody can be used to measure free romosozumab levels in serum from patients. Clone AbD60146 is available as a monovalent Fab antibody incorporating a SpyTag at the C-terminus end of the antibody heavy chain for conversion by the end user into alternative formats using any of the SpyCatchers available in our catalog under product code TZA061. It is also available as a bivalent Fab antibody already conjugated to HRP via coupling to the HRP conjugated BiSpyCatcher2 (TZC002P) for use in direct ELISA under product code TZA061P. A pair of anti-romosozumab antibodies can be used to develop a pharmacokinetic (PK) bridging assay to measure free drug; clone AbD60146 is recommended as a detection antibody, paired with Human Anti-Romosozumab Antibody, clone AbD60141ad (TZA060) as the capture reagent. Romosozumab (trade name Evenity) is a humanized monoclonal antibody of the IgG2/kappa isotype that binds to sclerostin and prevents inhibition of the Wnt signaling pathway, thereby promoting osteogenesis and, to a lesser extent, reducing bone resorption. Romosozumab's inhibition of sclerostin also inhibits the increase in RANKL-dependent increases in osteoclast activity and bone resorption. Romosozumab is indicated for the treatment of osteoporosis in postmenopausal women at high risk for fracture. View a summary of all anti-romosozumab antibodies |
- Product Form
- A bivalent human recombinant Fab (kappa light chain) generated by coupling of the monovalent SpyTagged Fab TZA061 with a HRP conjugated BiSpyCatcher version 2. The coupled antibody has two DYKDDDDK tags and three His6-tags. It contains SpyTag3 peptide (BLP086) in 5-fold molar excess to block any unreacted Catcher sites. This antibody is supplied as a liquid.
- Preparation
- Metal chelate affinity chromatography
- Source
- E.coli
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.0095% MIT
- Immunogen
- Romosozumab
- Affinity
- The monovalent intrinsic affinity of AbD60146pap was measured as KD = 0.4 nM by real time, label free molecular interaction analysis on immobilized romosozumab.
- Approx. Protein Concentrations
- Antibody concentration 0.5 mg/ml
- Regulatory
- For research purposes only
- Guarantee
- 12 months from date of despatch
- Acknowledgements
- This product and/or its use is covered by claims of U.S. patents, and/or pending U.S. and non-U.S. patent applications owned by or under license to Bio-Rad Laboratories, Inc. See bio-rad.com/en-us/trademarks for details.
His-tag is a registered trademark of EMD Biosciences. Evenity is a trademark of Amgen and UCB. - Licensed Use
- For in vitro research purposes and for commercial applications for the provision of in vitro testing services to support preclinical and clinical drug development. Any re-sale in any form or any other commercial application needs a written agreement with Bio-Rad.
When ready to use, thaw and aliquot the sample as needed. Store aliquots at -70°C, if available, otherwise store at -20°C. It is not recommended to keep aliquots at 4°C for more than one week.
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA |
- Technical Advice
- Recommended protocols for coupling a Fab antibody with a SpyTag to a SpyCatcher can be found at SpyTag and SpyCatcher Products, and further information about HuCAL recombinant antibody technology can be found in the HuCAL Antibodies Technical Manual
- ELISA
- Clone AbD60146pap can be used in direct ELISA to detect romosozumab. It can also be used as a detection antibody to develop a pharmacokinetic (PK) bridging ELISA for romosozumab together with TZA060 as the capture reagent.
Protocol: PK bridging ELISA
| Description | Product Code | Applications | Pack Size | List Price | Your Price | Quantity | |
|---|---|---|---|---|---|---|---|
| Hispec Assay Diluent | BUF049A | E IY | 50 ml | Log in | |||
| List Price | Your Price | ||||||
| Log in | |||||||
| Description | Hispec Assay Diluent | ||||||
| Human anti Romosozumab | HCA423 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Romosozumab | ||||||
| Human anti Romosozumab | TZA060 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Romosozumab | ||||||
| Human anti Romosozumab | TZA061 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Romosozumab | ||||||
| Human anti Romosozumab (Drug/Target Complex) | TZA099 | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Romosozumab (Drug/Target Complex) | ||||||
| Human anti Romosozumab (Drug/Target Complex):HRP | TZA099P | E | 0.1 mg |
|
Log in | ||
| List Price | Your Price | ||||||
|
|
Log in | ||||||
| Description | Human anti Romosozumab (Drug/Target Complex):HRP | ||||||
- Synonyms
- Evenity
TZA061P
If you cannot find the batch/lot you are looking for please contact our technical support team for assistance.
Please Note: All Products are "FOR RESEARCH PURPOSES ONLY"
Always be the first to know.
When we launch new products and resources to help you achieve more in the lab.
Yes, sign me up